Penumbra, Inc. has grown revenue 18% a year over three years and 20% a year over five, with earnings per share compounding at 200%. Revenue growth, 3-year annual rate: +18% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +20%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +200%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 13, FY2013 to FY2025, as filed.

PENPenumbra, Inc.

HealthcareUSD

$323.27

$225.5452 weeks$359.40

Is it growing?

Is PEN growing?

Penumbra, Inc. has grown revenue 18% a year over three years and 20% a year over five, with earnings per share compounding at 200%.

+18%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +20%
Revenue growth, 5-year rate · +18% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +200%
Earnings per share, 3-year rate · revenue +18% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed